ID   NRX1B_RAT               Reviewed;         468 AA.
AC   Q63373;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 174.
DE   RecName: Full=Neurexin-1-beta {ECO:0000305};
DE   AltName: Full=Neurexin I-beta;
DE   Flags: Precursor;
GN   Name=Nrxn1 {ECO:0000312|RGD:628659};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=1621094; DOI=10.1126/science.1621094;
RA   Ushkaryov Y.A., Petrenko A.G., Geppert M., Suedhof T.C.;
RT   "Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin
RT   receptor and laminin.";
RL   Science 257:50-56(1992).
RN   [2]
RP   PROTEIN SEQUENCE OF N-TERMINUS, AND GLYCOSYLATION.
RC   TISSUE=Brain;
RX   PubMed=8163501; DOI=10.1016/s0021-9258(17)32671-6;
RA   Ushkaryov Y.A., Hata Y., Ichtchenko K., Moomaw C., Afendis S.,
RA   Slaughter C.A., Suedhof T.C.;
RT   "Conserved domain structure of beta-neurexins. Unusual cleaved signal
RT   sequences in receptor-like neuronal cell-surface proteins.";
RL   J. Biol. Chem. 269:11987-11992(1994).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH NLGN1.
RX   PubMed=9325340; DOI=10.1074/jbc.272.41.26032;
RA   Nguyen T., Suedhof T.C.;
RT   "Binding properties of neuroligin 1 and neurexin 1beta reveal function as
RT   heterophilic cell adhesion molecules.";
RL   J. Biol. Chem. 272:26032-26039(1997).
RN   [4]
RP   INTERACTION WITH NLGN1; NLGN2 AND NLGN3, AND REGION.
RX   PubMed=8576240; DOI=10.1074/jbc.271.5.2676;
RA   Ichtchenko K., Nguyen T., Suedhof T.C.;
RT   "Structures, alternative splicing, and neurexin binding of multiple
RT   neuroligins.";
RL   J. Biol. Chem. 271:2676-2682(1996).
RN   [5]
RP   INTERACTION WITH CASK.
RX   PubMed=8786425; DOI=10.1523/jneurosci.16-08-02488.1996;
RA   Hata Y., Butz S., Suedhof T.C.;
RT   "CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent
RT   protein kinase domain identified by interaction with neurexins.";
RL   J. Neurosci. 16:2488-2494(1996).
RN   [6]
RP   INTERACTION WITH ALPHA-LATROTOXIN, AND REGION.
RX   PubMed=10197529; DOI=10.1016/s0896-6273(00)80704-7;
RA   Sugita S., Khvochtev M., Suedhof T.C.;
RT   "Neurexins are functional alpha-latrotoxin receptors.";
RL   Neuron 22:489-496(1999).
RN   [7]
RP   INTERACTION WITH DAG1 (ALPHA-DYSTROGLYCAN), AND REGION.
RX   PubMed=11470830; DOI=10.1083/jcb.200105003;
RA   Sugita S., Saito F., Tang J., Satz J., Campbell K., Suedhof T.C.;
RT   "A stoichiometric complex of neurexins and dystroglycan in brain.";
RL   J. Cell Biol. 154:435-445(2001).
RN   [8]
RP   SUBUNIT.
RX   PubMed=17042500; DOI=10.1021/bi0614131;
RA   Comoletti D., Flynn R.E., Boucard A.A., Demeler B., Schirf V., Shi J.,
RA   Jennings L.L., Newlin H.R., Sudhof T.C., Taylor P.;
RT   "Gene selection, alternative splicing, and post-translational processing
RT   regulate neuroligin selectivity for beta-neurexins.";
RL   Biochemistry 45:12816-12827(2006).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17868325; DOI=10.1111/j.1471-4159.2007.04918.x;
RA   Berninghausen O., Rahman M.A., Silva J.P., Davletov B., Hopkins C.,
RA   Ushkaryov Y.A.;
RT   "Neurexin Ibeta and neuroligin are localized on opposite membranes in
RT   mature central synapses.";
RL   J. Neurochem. 103:1855-1863(2007).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 47-302.
RX   PubMed=10520997; DOI=10.1016/s0092-8674(00)80065-3;
RA   Rudenko G., Nguyen T., Chelliah Y., Suedhof T.C., Deisenhofer J.;
RT   "The structure of the ligand-binding domain of neurexin Ibeta: regulation
RT   of LNS domain function by alternative splicing.";
RL   Cell 99:93-101(1999).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.9 ANGSTROMS) OF 80-288 IN COMPLEX WITH HUMAN
RP   NLGN4X, AND CALCIUM-BINDING SITES.
RX   PubMed=18093521; DOI=10.1016/j.neuron.2007.11.013;
RA   Fabrichny I.P., Leone P., Sulzenbacher G., Comoletti D., Miller M.T.,
RA   Taylor P., Bourne Y., Marchot P.;
RT   "Structural analysis of the synaptic protein neuroligin and its beta-
RT   neurexin complex: determinants for folding and cell adhesion.";
RL   Neuron 56:979-991(2007).
CC   -!- FUNCTION: Neuronal cell surface protein that may be involved in cell
CC       recognition and cell adhesion by forming intracellular junctions
CC       through binding to neuroligins (PubMed:9325340). Plays a role in
CC       formation of synaptic junctions (By similarity).
CC       {ECO:0000250|UniProtKB:P0DI97, ECO:0000269|PubMed:9325340}.
CC   -!- SUBUNIT: The cytoplasmic C-terminal region binds to CASK
CC       (PubMed:8786425). Binds NLGN1, NLGN2 and NLGN3, DAG1 (alpha-
CC       dystroglycan) and alpha-latrotoxin. Binding to neuroligins is calcium-
CC       dependent, and the binding preference ranks as follow: NLGN1 > NLGN4 >>
CC       NLGN3 > NLGN2 (PubMed:10197529, PubMed:11470830, PubMed:17042500,
CC       PubMed:8576240, PubMed:9325340). Interacts with CBLN2 and more weakly
CC       with CBLN4 (By similarity). Interacts with CBLN1; interaction is CBLN1
CC       hexamer form-dependent; CBLN1-binding is calcium-independent; isoform
CC       1b does not interact with CBLN1 (By similarity). Interacts with CLSTN3
CC       (By similarity). {ECO:0000250|UniProtKB:P0DI97,
CC       ECO:0000250|UniProtKB:P58400, ECO:0000269|PubMed:10197529,
CC       ECO:0000269|PubMed:11470830, ECO:0000269|PubMed:17042500,
CC       ECO:0000269|PubMed:8576240, ECO:0000269|PubMed:8786425,
CC       ECO:0000269|PubMed:9325340}.
CC   -!- INTERACTION:
CC       Q63373; O14936: CASK; Xeno; NbExp=3; IntAct=EBI-1780696, EBI-1215506;
CC       Q63373-3; Q62765-2: Nlgn1; NbExp=5; IntAct=EBI-20994045, EBI-20994039;
CC       Q63373-3; Q8N0W4: NLGN4X; Xeno; NbExp=5; IntAct=EBI-20994045, EBI-2862707;
CC   -!- SUBCELLULAR LOCATION: Presynaptic cell membrane
CC       {ECO:0000269|PubMed:17868325}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:17868325}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=17;
CC         Comment=Two isoform types, alpha-type and beta-type are produced by
CC         alternative promoter usage. In addition there are at least five
CC         alternatively spliced sites, each of which may be spliced in up to
CC         seven different ways. Combinatorial splicing at each of these five
CC         sites may lead to the generation of at least 96 isoforms but for
CC         simplicity only individual splice events or observed combinations are
CC         explicitly described below. Beta-type isoforms share the possibility
CC         of alternative splicing at sites 4 and 5. Experimental confirmation
CC         may be lacking for some isoforms.;
CC       Name=1b; Synonyms=Beta-4A5A;
CC         IsoId=Q63373-1; Sequence=Displayed;
CC       Name=2b; Synonyms=Beta-4A5B;
CC         IsoId=Q63373-2; Sequence=VSP_003497;
CC       Name=3b; Synonyms=Beta-4B5A;
CC         IsoId=Q63373-3; Sequence=VSP_003496;
CC       Name=4b; Synonyms=Beta-4B5B;
CC         IsoId=Q63373-4; Sequence=VSP_003496, VSP_003497;
CC       Name=1a; Synonyms=Alpha-1A2A3A4A5A;
CC         IsoId=Q63372-2; Sequence=External;
CC       Name=2a; Synonyms=Alpha-1B;
CC         IsoId=Q63372-1; Sequence=External;
CC       Name=3a; Synonyms=Alpha-1C;
CC         IsoId=Q63372-3; Sequence=External;
CC       Name=4a; Synonyms=Alpha-1D;
CC         IsoId=Q63372-4; Sequence=External;
CC       Name=5a; Synonyms=Alpha-1E;
CC         IsoId=Q63372-5; Sequence=External;
CC       Name=6a; Synonyms=Alpha-1F;
CC         IsoId=Q63372-6; Sequence=External;
CC       Name=7a; Synonyms=Alpha-1G;
CC         IsoId=Q63372-7; Sequence=External;
CC       Name=8a; Synonyms=Alpha-2B;
CC         IsoId=Q63372-8; Sequence=External;
CC       Name=9a; Synonyms=Alpha-2C;
CC         IsoId=Q63372-9; Sequence=External;
CC       Name=10a; Synonyms=Alpha-3B;
CC         IsoId=Q63372-10; Sequence=External;
CC       Name=11a; Synonyms=Alpha-4B;
CC         IsoId=Q63372-11; Sequence=External;
CC       Name=12a; Synonyms=Alpha-5B;
CC         IsoId=Q63372-12; Sequence=External;
CC       Name=13a; Synonyms=Alpha-1B2B;
CC         IsoId=Q63372-13; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:8163501}.
CC   -!- PTM: O-glycosylated; contains heparan sulfate. Heparan sulfate
CC       attachment is required for synapse development by mediating
CC       interactions with neuroligins. {ECO:0000250|UniProtKB:P0DI97}.
CC   -!- SIMILARITY: Belongs to the neurexin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M96375; AAA41705.1; -; mRNA.
DR   PIR; B40228; B40228.
DR   PDB; 1C4R; X-ray; 2.60 A; A/B/C/D/E/F/G/H=81-292.
DR   PDB; 2R1B; X-ray; 1.72 A; A/B=77-294.
DR   PDB; 2R1D; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/W=48-302.
DR   PDB; 2WQZ; X-ray; 3.90 A; C/D=80-288.
DR   PDB; 2XB6; X-ray; 2.60 A; C/D=80-288.
DR   PDBsum; 1C4R; -.
DR   PDBsum; 2R1B; -.
DR   PDBsum; 2R1D; -.
DR   PDBsum; 2WQZ; -.
DR   PDBsum; 2XB6; -.
DR   AlphaFoldDB; Q63373; -.
DR   EMDB; EMD-6666; -.
DR   SMR; Q63373; -.
DR   ComplexPortal; CPX-4061; NLGN1(-SSA-SSB) - NRXN1-beta(-SS4) complex. [Q63373-3]
DR   ComplexPortal; CPX-4123; NLGN1(+SSA+SSB) - NRXN1-beta(-SS4) complex. [Q63373-3]
DR   DIP; DIP-40508N; -.
DR   IntAct; Q63373; 5.
DR   MINT; Q63373; -.
DR   GlyCosmos; Q63373; 1 site, No reported glycans.
DR   PaxDb; 10116-ENSRNOP00000066979; -.
DR   ABCD; Q63373; 2 sequenced antibodies.
DR   UCSC; RGD:628659; rat. [Q63373-1]
DR   AGR; RGD:628659; -.
DR   RGD; 628659; Nrxn1.
DR   eggNOG; KOG3514; Eukaryota.
DR   PhylomeDB; Q63373; -.
DR   EvolutionaryTrace; Q63373; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0044295; C:axonal growth cone; ISS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0060076; C:excitatory synapse; NAS:ComplexPortal.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0060077; C:inhibitory synapse; NAS:ComplexPortal.
DR   GO; GO:0031594; C:neuromuscular junction; NAS:ComplexPortal.
DR   GO; GO:0098984; C:neuron to neuron synapse; NAS:ComplexPortal.
DR   GO; GO:0043025; C:neuronal cell body; ISS:BHF-UCL.
DR   GO; GO:0031965; C:nuclear membrane; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; NAS:ComplexPortal.
DR   GO; GO:0048787; C:presynaptic active zone membrane; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:BHF-UCL.
DR   GO; GO:0098635; C:protein complex involved in cell-cell adhesion; IPI:ComplexPortal.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0036057; C:slit diaphragm; IDA:RGD.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0033130; F:acetylcholine receptor binding; ISO:RGD.
DR   GO; GO:0005246; F:calcium channel regulator activity; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0048306; F:calcium-dependent protein binding; ISS:BHF-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0097109; F:neuroligin family protein binding; IPI:ARUK-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:BHF-UCL.
DR   GO; GO:0005105; F:type 1 fibroblast growth factor receptor binding; ISO:RGD.
DR   GO; GO:0030534; P:adult behavior; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:BHF-UCL.
DR   GO; GO:0090125; P:cell-cell adhesion involved in synapse maturation; NAS:ComplexPortal.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:ARUK-UCL.
DR   GO; GO:0021707; P:cerebellar granule cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0045184; P:establishment of protein localization; ISS:BHF-UCL.
DR   GO; GO:0046847; P:filopodium assembly; ISO:RGD.
DR   GO; GO:0097112; P:gamma-aminobutyric acid receptor clustering; ISS:BHF-UCL.
DR   GO; GO:0097116; P:gephyrin clustering involved in postsynaptic density assembly; ISS:BHF-UCL.
DR   GO; GO:0097117; P:guanylate kinase-associated protein clustering; ISS:BHF-UCL.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:BHF-UCL.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0099558; P:maintenance of synapse structure; NAS:ComplexPortal.
DR   GO; GO:0051490; P:negative regulation of filopodium assembly; ISS:BHF-UCL.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0097118; P:neuroligin clustering involved in postsynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; ISS:BHF-UCL.
DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0048812; P:neuron projection morphogenesis; NAS:ComplexPortal.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0097114; P:NMDA glutamate receptor clustering; ISS:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1900075; P:positive regulation of neuromuscular synaptic transmission; NAS:ComplexPortal.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; NAS:ComplexPortal.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:1905520; P:positive regulation of presynaptic active zone assembly; TAS:BHF-UCL.
DR   GO; GO:0010739; P:positive regulation of protein kinase A signaling; ISO:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0090129; P:positive regulation of synapse maturation; ISO:RGD.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; NAS:ComplexPortal.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL.
DR   GO; GO:0097119; P:postsynaptic density protein 95 clustering; ISS:BHF-UCL.
DR   GO; GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0099054; P:presynapse assembly; IDA:SynGO.
DR   GO; GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0035418; P:protein localization to synapse; ISS:BHF-UCL.
DR   GO; GO:0090126; P:protein-containing complex assembly involved in synapse maturation; ISS:BHF-UCL.
DR   GO; GO:0097120; P:receptor localization to synapse; ISS:BHF-UCL.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; ISS:BHF-UCL.
DR   GO; GO:2000821; P:regulation of grooming behavior; ISO:RGD.
DR   GO; GO:2000310; P:regulation of NMDA receptor activity; ISS:BHF-UCL.
DR   GO; GO:0099151; P:regulation of postsynaptic density assembly; ISO:RGD.
DR   GO; GO:0099150; P:regulation of postsynaptic specialization assembly; ISO:RGD.
DR   GO; GO:1905606; P:regulation of presynapse assembly; ISO:RGD.
DR   GO; GO:0098693; P:regulation of synaptic vesicle cycle; ISO:RGD.
DR   GO; GO:0150036; P:regulation of trans-synaptic signaling by endocannabinoid, modulating synaptic transmission; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; IDA:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; ISO:RGD.
DR   GO; GO:0007416; P:synapse assembly; ISS:BHF-UCL.
DR   GO; GO:0060074; P:synapse maturation; NAS:ComplexPortal.
DR   GO; GO:0099560; P:synaptic membrane adhesion; ISO:RGD.
DR   GO; GO:0097091; P:synaptic vesicle clustering; ISS:BHF-UCL.
DR   GO; GO:0099550; P:trans-synaptic signaling, modulating synaptic transmission; ISO:RGD.
DR   GO; GO:0042297; P:vocal learning; ISO:RGD.
DR   GO; GO:0071625; P:vocalization behavior; ISO:RGD.
DR   CDD; cd00110; LamG; 1.
DR   Gene3D; 2.60.120.200; -; 1.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR050372; Neurexin-related_CASP.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   PANTHER; PTHR15036:SF51; NEUREXIN-1; 1.
DR   PANTHER; PTHR15036; PIKACHURIN-LIKE PROTEIN; 1.
DR   Pfam; PF02210; Laminin_G_2; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00282; LamG; 1.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   Angiogenesis; Calcium; Cell adhesion; Cell membrane; Cell projection;
KW   Direct protein sequencing; Glycoprotein; Heparan sulfate; Membrane;
KW   Metal-binding; Phosphoprotein; Proteoglycan; Reference proteome; Repeat;
KW   Signal; Synapse; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..46
FT                   /evidence="ECO:0000269|PubMed:8163501"
FT   CHAIN           47..468
FT                   /note="Neurexin-1-beta"
FT                   /id="PRO_0000019494"
FT   TOPO_DOM        47..391
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        392..414
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        415..468
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          87..285
FT                   /note="Laminin G-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   REGION          201..230
FT                   /note="Essential for interaction with CBLN1; modulates
FT                   interaction affinity with NLGN1, NLGN2 and NLGN3; prevents
FT                   interaction with DAG1/alpha-dystroglycan; modulates
FT                   interaction with alpha-latrotoxin"
FT                   /evidence="ECO:0000250|UniProtKB:P58400,
FT                   ECO:0000269|PubMed:10197529, ECO:0000269|PubMed:11470830,
FT                   ECO:0000269|PubMed:8576240"
FT   REGION          350..381
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          435..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..451
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        452..468
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         137
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:18093521"
FT   BINDING         154
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:18093521"
FT   BINDING         236
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:18093521"
FT   BINDING         238
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:18093521"
FT   MOD_RES         450
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58400"
FT   MOD_RES         451
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58400"
FT   MOD_RES         454
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58400"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        346
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DI97"
FT   VAR_SEQ         201..230
FT                   /note="Missing (in isoform 3b and isoform 4b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003496"
FT   VAR_SEQ         363..468
FT                   /note="Missing (in isoform 2b and isoform 4b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003497"
FT   STRAND          84..99
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          108..118
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          122..132
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          138..144
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          147..157
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          159..162
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          170..172
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          174..181
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          184..189
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          195..197
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   HELIX           218..232
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   HELIX           233..235
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          240..247
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   TURN            248..251
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          256..263
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   HELIX           268..273
FT                   /evidence="ECO:0007829|PDB:2R1B"
FT   STRAND          279..287
FT                   /evidence="ECO:0007829|PDB:2R1B"
SQ   SEQUENCE   468 AA;  50268 MW;  B24A3CEFF5A2394E CRC64;
     MYQRMLRCGA ELGSPGGGSS GGAGGRLALL WIVPLTLSGL LGVAWGASSL GAHHIHHFHG
     SSKHHSVPIA IYRSPASLRG GHAGTTYIFS KGGGQITYKW PPNDRPSTRA DRLAIGFSTV
     QKEAVLVRVD SSSGLGDYLE LHIHQGKIGV KFNVGTDDIA IEESNAIIND GKYHVVRFTR
     SGGNATLQVD SWPVIERYPA GNNDNERLAI ARQRIPYRLG RVVDEWLLDK GRQLTIFNSQ
     ATIIIGGKEQ GQPFQGQLSG LYYNGLKVLN MAAENDANIA IVGNVRLVGE VPSSMTTEST
     ATAMQSEMST SIMETTTTLA TSTARRGKPP TKEPISQTTD DILVASAECP SDDEDIDPCE
     PSSGGLANPT RVGGREPYPG SAEVIRESSS TTGMVVGIVA AAALCILILL YAMYKYRNRD
     EGSYHVDESR NYISNSAQSN GAVVKEKQPS SAKSANKNKK NKDKEYYV
//
